All In Biotech

Drug Trial Radar · NCT00542425

Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis

A Randomized, Parallel-Group, Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis

Last checked: Nov 20, 2026Latest source record: Oct 30, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 222 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

222

Actual

Start

Apr 2007

Primary completion

Jun 2009

Study completion Jun 2009

Sponsor

Lead sponsor
Radius Health, Inc.Industry
Sponsor type
Industry
First posted
Oct 11, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
Female only, from 55 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether BA058 is effective in building bone in postmenopausal women with osteoporosis.

Conditions

  • Osteoporosis

Interventions

  • teriparatideDrug

    teriparatide 20 µg subcutaneous daily

  • PlaceboDrug

    Placebo subcutaneous daily

  • BA058 20 µgDrug

    BA058 20 µg subcutaneous daily

  • BA058 40 µgDrug

    BA058 40 µg subcutaneous daily

  • BA058 80 µgDrug

    BA058 80 µg subcutaneous daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Marker of Bone Metabolism, PINPTime frame: 6 months
  2. Change in Bone Mineral Density, Total Spine.Time frame: 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Radius Health, Inc.

    Cambridge, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.